| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |